Zimbabwe Top News Stories – November 2025

November 2025 was a transformative month for Zimbabwe, marked by major foreign investment announcements, groundbreaking health advancements, and significant shifts in international development assistance. Here’s a comprehensive look at the stories that defined the month.

Dangote’s $1 Billion Investment Deal: A Vote of Confidence

The most significant economic news of November came on November 12, when Nigerian billionaire Aliko Dangote signed a landmark $1 billion investment agreement with President Emmerson Mnangagwa. This comprehensive deal represents one of the largest private sector investments in Zimbabwe’s recent history and spans multiple crucial sectors.

The Investment Package

The Dangote Group’s investment will focus on four main areas:

Cement Production: The centerpiece is a $400 million cement plant in the Masvingo region with an annual production capacity of 1.5 million tonnes. This facility will tap into local limestone quarries and aims to dramatically reduce Zimbabwe’s 70% reliance on imported cement. With cement prices having surged by 42% in October and November 2025 due to a construction boom and supply constraints, this investment comes at a critical time.

Power Generation: A $300 million power generation project, likely coal-fired with a capacity of 300MW, will draw from the Sengwa coal fields. This component addresses Zimbabwe’s chronic energy crisis, where blackouts cost the economy an estimated $1.5 billion annually.

Fuel Infrastructure: Perhaps most ambitiously, the deal includes a 2,000-2,200 kilometer fuel pipeline from Walvis Bay, Namibia, running through Botswana to Harare. This infrastructure will transport petroleum products into landlocked Zimbabwe, potentially transforming the country’s fuel supply chain.

Additional Sectors: The investment also covers coal mining and fertilizer manufacturing, creating an integrated industrial complex that could generate thousands of direct and indirect jobs.

Context and Significance

Dangote’s commitment is particularly meaningful given the history between the investor and Zimbabwe. The billionaire first explored opportunities in Zimbabwe in 2015 and 2018, but those discussions stalled due to bureaucratic hurdles and regulatory opacity under the Mugabe regime. His return signals growing confidence in the current government’s business environment.

The timing aligns with Zimbabwe’s improving economic indicators. The country is projected to achieve 6% GDP growth in 2025, supported by agricultural recovery and strong commodity prices. President Mnangagwa’s Vision 2030 agenda, which aims to transform Zimbabwe into an upper-middle-income economy, received a significant boost from this partnership.

IMF Upgrades Economic Outlook

In early November, an International Monetary Fund mission visited Harare from October 29 to November 5, and the results were encouraging. The IMF upgraded Zimbabwe’s 2025 economic outlook, citing stronger-than-expected recovery driven by several factors.

According to IMF mission chief Wojciech Maliszewski, the country’s economic rebound has been supported by agricultural recovery, solid mining sector performance, and easing inflation amid exchange rate stability. The revised forecast represents a notable shift from earlier, more cautious projections that had been tempered by concerns about fiscal pressures and inflationary risks.

The IMF emphasized the importance of fiscal discipline in the 2026 budget, urging the government to align expenditures with revenues and sustainable financing sources. The mission also addressed Zimbabwe’s request for a Staff Monitored Programme, which would support reforms aimed at sustaining macroeconomic stability.

Low inflation, currently at 0.5% month-on-month, combined with exchange rate steadiness, has helped rebuild investor confidence. The upgraded forecast is expected to further boost international interest in Zimbabwe’s economy and support efforts to re-engage with global financial institutions.

Groundbreaking HIV Prevention Approval

In a remarkable achievement for public health, Zimbabwe’s Medicines Control Authority (MCAZ) approved lenacapavir in just 23 days, making the country one of the first in Africa to authorize this revolutionary HIV prevention drug.

About Lenacapavir

Lenacapavir is the world’s first twice-yearly injectable pre-exposure prophylaxis (PrEP) for HIV. Unlike daily oral pills, this long-acting medication requires only two injections per year, offering a practical solution for people who face challenges with adherence, stigma, or limited healthcare access.

The application, submitted by U.S. pharmaceutical company Gilead Sciences on October 29, was approved by November 21 under MCAZ’s expedited regulatory process. MCAZ Director-General Richard T. Rukwata emphasized that the rapid approval reflected the authority’s dedication to accelerating access to high-quality health products.

Regional Context

Zimbabwe’s approval followed South Africa’s authorization on October 27 and came alongside Zambia’s approval on November 4. The approvals were made possible through the WHO Listed Authorities Collaborative Registration Procedure, a reliance-based pathway that allows countries to leverage assessments from trusted regulatory authorities.

This breakthrough is particularly significant for Zimbabwe, which has one of the world’s highest HIV prevalence rates, with 1.3 million people living with HIV. The drug’s twice-yearly dosing schedule is expected to dramatically improve adherence rates and expand prevention options for the most vulnerable populations.

Zimbabwe was also selected by the United States as one of just 10 countries worldwide to receive priority access to lenacapavir under a new global delivery program, which aims to supply the first 600,000 doses in 2026 to high-burden countries.

Cement Crisis and Import Relief

November saw Zimbabwe grappling with a severe cement shortage that sent prices soaring by 42% in October and November. The crisis, attributed to a construction boom, limited local production, and constrained imports, led to vendors running out of stock across the country.

Deputy Minister of Industry and Commerce Raj Modi announced that the government was taking remedial action by issuing licenses to import approximately 150,000 tonnes of cement from October 2025 onwards. He acknowledged that there was a backlog of cement at the border and noted that the country faces a clinker shortage, with only PPC currently manufacturing it locally.

The timing of Dangote’s cement plant announcement couldn’t have been better. With the country clearly needing more local producers and prices at crisis levels, the promise of 1.5 million tonnes of annual production capacity offers hope for stabilizing the construction sector.

Meanwhile, positive developments emerged on the local production front. Sino Zimbabwe reportedly restarted clinker production in late November 2025, while China-based cement projects in Chegutu and Magunje continued their development, though the latter faced environmental compliance challenges.

Sweden Cuts Development Aid

In a significant shift in international relations, Sweden announced in early December (based on developments in late November) that it would gradually phase out development aid to Zimbabwe and four other countries—Tanzania, Mozambique, Liberia, and Bolivia—over the coming years.

Minister for International Development Cooperation and Foreign Trade Benjamin Dousa explained that the decision reflects a reallocation of Sweden’s development budget priorities in response to geopolitical developments, particularly redirecting funds to increase support for Ukraine. The government plans to boost aid to Ukraine to at least $1.06 billion in 2026.

Officials indicated the transition would occur gradually to allow affected countries to adjust and seek alternative support sources. This marks a significant change for Zimbabwe, which has relied on various forms of Swedish development assistance. Sweden has already cut aid to more than 10 countries since the current government took power in 2022, including Burkina Faso and Mali.

The announcement underscores the shifting landscape of international development assistance and the need for countries like Zimbabwe to diversify their economic partnerships and reduce dependence on traditional donor funding.

Looking Ahead

As November closed, Zimbabwe found itself at an inflection point. The country attracted significant private investment, achieved important health milestones, and demonstrated improving macroeconomic fundamentals. However, challenges remain, including managing the transition away from some traditional development partnerships and ensuring that major investment commitments translate into tangible economic benefits for ordinary Zimbabweans.

The Dangote investment, if successfully implemented, could be transformative—providing jobs, addressing infrastructure gaps, and demonstrating that Zimbabwe is open for business. The rapid approval of lenacapavir shows the country’s capacity for agile governance when public health demands it. And the IMF’s upgraded outlook provides validation that economic reforms are bearing fruit.

The coming months will be crucial as these various initiatives move from announcement to implementation, determining whether November 2025 will be remembered as a turning point in Zimbabwe’s economic trajectory.

---

These developments from November 2025 illustrate Zimbabwe’s complex position—balancing major investment opportunities, public health innovation, and shifting international partnerships as the country works toward its Vision 2030 goals.